Quadruple Immunotherapy for Neuroblastoma

Clinical trial NCT05754684 · RECRUITING

Trial details

NCT number: NCT05754684
Sponsor: Hong Kong Children's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Recurrent

Start date: 2022-01-01
Primary completion: 2025-12-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.